Home
Conditions
Myeloproliferative Disorders

Clinical trial condition

Myeloproliferative Disorders

Explore clinical trials studying Myeloproliferative Disorders. Study availability and eligibility vary by location and protocol.

500 public trials 86 recruiting studies

Refine in advanced search Browse all conditions

Myeloproliferative Disorders trial results

Completed

Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain

NCT00666211

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +108 more
Locations: Jennie Stuart Medical Center Hopkinsville, Kentucky, United States

Mitchell Memorial Cancer Center at Owensboro Medical Health System Owensboro, Kentucky, United States

Erlanger Health System Chattanooga, Tennessee, United States

Tennessee Plateau Oncology Crossville, Tennessee, United States

View Trial Details

Completed

Low-Intensity Preparation and Allogeneic Transplant in Patients With Cancers of the Blood

NCT00146055

Conditions: Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +21 more
Locations: The University of Michigan Ann Arbor, Michigan, United States

View Trial Details

Completed

A Phase I Trial of ZIO-101 in Hematologic Cancers

NCT00592046

Conditions: Acute Leukemia, Anemia, Anemia, Refractory, +31 more
Locations: Houston, Texas, United States

View Trial Details

Completed

Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation of Patients With Hematological Diseases

NCT00056966

Conditions: Anemia, Anemia, Aplastic, Blood Protein Disorders, +35 more
Locations: Texas Children's Hospital Houston, Texas, United States

The Methodist Hospital Houston, Texas, United States

View Trial Details

Completed

Busulfan and Cyclophosphamide Followed by Bone Marrow Transplantation in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome

NCT00004896

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +25 more
Locations: Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States

View Trial Details

Completed

Chemotherapy Plus Bone Marrow Transplantation and Filgrastim in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome

NCT00004899

Conditions: Bone Marrow Diseases, Chronic Disease, Congenital Abnormalities, +20 more
Locations: Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States

View Trial Details

Completed

Bone Marrow Transplantation in Treating Patients With Multiple Myeloma, Chronic Phase Chronic Myelogenous Leukemia, or Agnogenic Myeloid Metaplasia

NCT00004181

Conditions: Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +25 more
Locations: Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States

View Trial Details

Completed

Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer or Hematologic Cancer

NCT00006225

Conditions: Blood Protein Disorders, Bone Marrow Diseases, Breast Cancer, +67 more
Locations: Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago, Illinois, United States

View Trial Details

Completed

Stem Cell Transplantation in Treating Patients With Hematologic Cancer

NCT00004904

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +87 more
Locations: Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago, Illinois, United States

View Trial Details

Completed

Bone Marrow and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer

NCT00004232

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +87 more
Locations: Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago, Illinois, United States

View Trial Details

Myeloproliferative Disorders

Myeloproliferative Disorders trial results

Related conditions